Centinel Spine’s prodisc revenue reached nearly $33 million in the second quarter, the company said July 22. Five things to know: 1. Prodisc sales reached a record high in the second quarter and represents a 47% increase year over year,…
Spinal Tech
Researchers at Royal College of Surgeons in Ireland University of Medicine and Health Sciences have developed a 3D-printed implant that delivers electrical stimulation to spinal cord injuries, potentially promoting nerve regrowth. Lab tests showed the device was able to deliver…
Dan Scavilla stepped down as president and CEO of Globus Medical, and Keith Pfeil succeeded him, the company said July 21. Mr. Scavilla resigned to pursue a new opportunity effective July 18, according to a news release. Mr. Pfeil, who…
The FDA cleared Rivanna’s SpineNav-AI image processing software and Accuro 3S diagnostic ultrasound system, according to a July 17 news release. SpineNav-AI is a machine-learning software that supports musculoskeletal imaging assessments of the lumbar spine. It uses AI-based image processing…
Globus Medical introduced its DuraPro drill with navigation for spine and orthopedic surgery, according to a July 16 news release. DuraPro helps prevent soft tissue wrapping and retains a natural sensation similar to spinning drills. The system integrates with ExcelsiusGPS…
Advertisement
SurGenTec launched the Insite sterile implant and instrument kit for sacroiliac joint fusion, the company said July 15. The Insite kit includes a set of single-use instruments with a 3D-printed titanium implant, according to a news release. The sterile set…
Carlsmed, a spine medtech company, launched its initial public offering of 6.7 million shares of common stock, according to a June 15 news release. Common stock price is expected to be between $14 and $16 per share, and the company…
Medtech company Wenzel Spine received FDA clearance for panaSIa, an expandable sacroiliac fusion implant. The implant offers a minimally invasive procedure option for patients with sacroiliac joint dysfunction, according to a July 15 news release from Wenzel Spine. The approval…
Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, which is designed for patients with degenerative disc disease.…
One name is behind two major sales in spine medtech in 2025. Investment firm Viscogliosi Brothers purchased key spinal assets from Stryker and Xtant Medical. Stryker sold its U.S. spine business, and Viscogliosi Brothers is using those assets to form…